Zelanex 5ml - 5ml

Drops

Pack Size : 1 Bottle x 1 Packet

Generics : Azelastine Hydrochloride

Manufacturer : Opsonin Pharma Ltd.

Best Price * TK 130.00

* Delivery will be done in Dhaka city only.

Alternative Product

More Information About - Zelanex 5ml - 5ml

Description

Generic Name

Azelastine Hydrochloride Nasal prep

Precaution

In clinical trials, the occurrence of somnolence has been reported in some patients taking Azelastine Hydrochloride Nasal Spray; due caution should therefore be exercised when driving a car or operating potentially dangerous machinery. Concurrent use of Azelastine Hydrochloride Nasal Spray with Alcohol or other CNS depressants should be avoided because additional reductions in alertness and additional impairment of CNS performance may occur. Lactation: Not known if excreted in breast milk; use caution

Indication

Allergic rhinitis, vasomotor rhinitis.

Contra Indication

Known hypersensitivity to Azelastine Hydrochloride or any of its components.

Dose

N/A

Side Effect

>10% Bitter taste (8-19.7%),Headache (8-14.8%),Somnolence (1-11.5%),Cold symptoms/rhinitis (2-17%),Cough (11%) 1-10% Nasal burning (4.1%),Sneezing (3.1%),Dry mouth (2.8%),Nausea (2.8%),Conjunctivitis (2-5%),Asthma (5%),Fatigue (2.3%),Rhinitis (2.3%),Pharyngitis (4%),Dizziness (2%),Weight increase (2%),Myalgia (<2%) <1% Amenorrhea,Breast pain,Constipation,Contact dermatitis,Eczema,Flushing,Glossitis,Hyperkinesia,Hypertension,Tachycardia,Vertigo,Vomiting

Pregnancy Category

Name : Not Classified

Description

FDA has not yet classified the drug into a specified pregnancy category.

Mode of Action

Azelastine blocks histamine H1-receptor activity and inhibits release of inflammatory mediators from mast cells.

Interaction

N/A

Pregnancy Category Note

Pregnancy Limited data from postmarketing experience over decades of use in pregnant women have not identified any drug associated risks of miscarriage, birth defects, or other adverse maternal or fetal outcomes Animal data In animal reproduction studies, there was no evidence of fetal harm at oral doses approximately 5 times the clinical daily dose; oral administration to pregnant mice, rats, and rabbits, during the period of organogenesis, produced developmental toxicity that included structural abnormalities, decreased embryo-fetal survival, and decreased fetal body weights at doses 270 times and higher than maximum recommended human daily intranasal dose of 1.096 mg; relevance of these findings in animals to pregnant women considered questionable based upon high animal to human dose multiple Lactation There are no data on presence in human milk, effects on breastfed infant, or on milk production; breastfed infants should be monitored for signs of milk rejection during use by lactating women; developmental and health benefits of breastfeeding should be considered along with mother?s clinical need for therapy and any potential adverse effects on breastfed infant from drug or from underlying maternal condition

Adult Dose

Allergic Rhinitis: Adults: 2 sprays per nostril twice daily.

Child Dose

Allergic Rhinitis: Children 5 years to 11 years of age: 1 spray into each nostril twice daily. Children >12 years: 2 sprays per nostril twice daily.

Renal Dose

N/A

Administration

Prime with 4 sprays before initial use; if idle for 3 days, reprime with 2 sprays

Disclaimer

The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.